Skip to main content
. 2007 Sep 5;57(5):611–622. doi: 10.1007/s00262-007-0399-8

Fig. 7.

Fig. 7

The correlation of anti-HER2 antibodies with prognoses of FVB-Tg. Correlation of total anti-HER2 Ig (a) or IgG2a (b) with tumor-free period (upper) and the number of primary tumors (middle) or lung metastases (lower) was evaluated with Spearman’s rank-order correlation coefficient and represents ρ values